share_log

T2 Biosystems | 4: Statement of changes in beneficial ownership of securities-Officer Gibbs Michael Terrence

T2 Biosystems | 4:持股变动声明-高管 Gibbs Michael Terrence

美股SEC公告 ·  2024/02/28 05:39

Moomoo AI 已提取核心信息

Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 24, 2024, involving the acquisition of 29 shares of common stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 135 shares in the company. The nature of the shares is direct, signifying personal ownership by Gibbs.
Michael Terrence Gibbs, General Counsel of T2 Biosystems, Inc. (TTOO), executed a transaction on February 24, 2024, involving the acquisition of 29 shares of common stock. The transaction was classified under the code 'M', indicating an exercise or conversion of derivative security. Following this transaction, Gibbs directly holds a total of 135 shares in the company. The nature of the shares is direct, signifying personal ownership by Gibbs.
T2 Biosystems, Inc.(TTOO)总法律顾问迈克尔·特伦斯·吉布斯于2024年2月24日执行了一项交易,涉及收购29股普通股。该交易被归类为'M',表示行使或转换衍生证券。在这笔交易之后,吉布斯直接持有该公司总共135股股份。股份的性质是直接的,表示吉布斯的个人所有权。
T2 Biosystems, Inc.(TTOO)总法律顾问迈克尔·特伦斯·吉布斯于2024年2月24日执行了一项交易,涉及收购29股普通股。该交易被归类为'M',表示行使或转换衍生证券。在这笔交易之后,吉布斯直接持有该公司总共135股股份。股份的性质是直接的,表示吉布斯的个人所有权。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息